Emergent BioSolutions, Inc. (EBS)
8.15
+0.09
(+1.12%)
USD |
NYSE |
May 20, 16:00
8.10
-0.05
(-0.61%)
After-Hours: 20:00
Emergent BioSolutions Total Assets (Quarterly) : 1.320B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.605B |
| Alnylam Pharmaceuticals, Inc. | 5.130B |
| Amgen, Inc. | 92.50B |
| Savara, Inc. | 221.64M |
| Biogen, Inc. | 29.48B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 797.30M |
| Shareholders Equity (Quarterly) | 523.10M |
| Debt to Equity Ratio | 1.214 |
| Current Ratio | 4.288 |
| Net Debt Paydown Yield | 1.91% |